Actively Recruiting
Novel Approach to Improve Patient Care and Diarrheal Disease Research Using Mobile Technology in Haiti
Led by University of Florida · Updated on 2025-06-30
7124
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
U
University of Florida
Lead Sponsor
F
Fogarty International Center of the National Institute of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to improve nighttime access to care and treatment for children in resource-limited settings, focusing on acute respiratory infections and diarrheal diseases, which are leading causes of death in children aged 1 month to 5 years globally. The study evaluates whether a digital clinical decision support (dCDS) tool used by a Telemedicine and Medication Delivery Service (TMDS) in Haiti can improve healthcare provider adherence to treatment guidelines. This effort builds on previous phases of research to develop a scalable telemedicine model called MotoMeds. The study compares two methods used by TMDS providers: the existing paper-based clinical decision support tools and the new digital clinical decision support tool. Providers will use these tools to assess and generate treatment plans for pediatric patients during calls. The study includes two intervention periods of 16 months each, separated by a 2-week washout period. The goal is to see if the digital tool improves guideline adherence and affects call duration and medication delivery times. Participants include children 10 years old or younger with acute illnesses whose parents or guardians contact the TMDS during its hours of operation. Consent is obtained either by a waiver for phone-only contacts or written consent/assent during household visits. Researchers will monitor outcomes such as the change in guideline adherence rates, clinical status at 10-day follow-up, call duration, and time to medication delivery. The study spans from September 2022 to September 2027, with ongoing assessments to measure the impact of the digital tool on care quality and delivery.
CONDITIONS
Brief Title
Improving Nighttime Access to Care and Treatment; Part 4-Haiti
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children 10 years of age or younger with an acute illness
- Parent or guardian contacts the Telemedicine and Medication Delivery Service during hours of operation
- Parent or guardian agrees to a waiver of consent for phone-only contact or provides written consent/assent during household visits
You will not qualify if you...
- No consent given by parent or guardian
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Two 16 month intervention periods with a 2 week washout in between
Participants receive consultations using either the paper-based or digital clinical decision support tools at the Telemedicine and Medication Delivery Service to assess and manage pediatric acute illnesses.
Phone consultations during service hours
Duration - 10 days
Participants' clinical status is evaluated approximately 10 days after the initial consultation to monitor health outcomes.
1 follow-up phone call
Trial Site Locations
Total: 1 location
1
CV Foundation
Gressier, Ouest, Haiti, HT-6160
Actively Recruiting
Research Team
M
Molly B Klarman, MPH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here